Welcome to our dedicated page for BlackRock Health Sciences Term Trust SEC filings (Ticker: BMEZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Access SEC filings for BlackRock Health Sciences Term Trust to gain comprehensive insights into the fund's operations, financial condition, portfolio holdings, and regulatory disclosures. As a registered closed-end investment company, BMEZ files regular reports with the Securities and Exchange Commission that provide transparency into fund activities and performance.
Key SEC filings for BMEZ include semi-annual reports (N-CSRS) and annual reports (N-CSR), which contain detailed financial statements, complete portfolio holdings lists, management discussion and analysis, and performance data. These reports provide shareholders with comprehensive information about the fund's investments, sector allocations, largest holdings, and financial condition as of the reporting date.
The fund also files Form N-PX annually, disclosing proxy voting records that show how the fund voted on shareholder proposals and corporate governance matters affecting portfolio companies. Form 497 filings include prospectus supplements and investor communications regarding significant fund events such as tender offers, distribution policy changes, or shareholder meetings.
Additionally, BMEZ files Form 8-K reports to disclose material events such as changes to distribution policies, the appointment of new portfolio managers, significant corporate actions, or other material developments that shareholders should be aware of. Registration statements and prospectuses provide detailed information about the fund's investment objectives, strategies, risks, fees, and terms.
Regular review of SEC filings enables investors to monitor portfolio composition changes, understand distribution sources, evaluate management's strategic decisions, and assess the fund's financial health. The filings also provide transparency into expense ratios, leverage utilization, derivative positions, and risk management practices.
BlackRock Health Sciences Term Trust director reports share sales in Form 4 filing. The director sold 10,294 common shares of BMEZ on 12/18/2025 at a price of $14.98 per share, followed by a sale of 0.422 share on 12/19/2025 at $14.96 per share. After these direct transactions, the director no longer held the shares directly. The filing also reports corresponding transactions in common stock held indirectly by the director's spouse on the same dates and prices, with those indirect holdings also reduced to zero. The report is filed for one reporting person, who serves as a director of the trust, and is signed by an attorney-in-fact.
FAQ
What is the current stock price of BlackRock Health Sciences Term Trust (BMEZ)?
What is the market cap of BlackRock Health Sciences Term Trust (BMEZ)?
